Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
Alberto J. Montero
ResearcherPublications, citations & collaboration network
Alberto J. Montero is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 336 works, 8,073 citations, an h-index of 44 and an i10-index of 110.
336
Works
8,073
Citations
44
h-index
110
i10-index
How has Alberto J. Montero's publication output changed over time?
ScholarIQpublication output · 2005–2022
Output grew100% over the shown period — from 1 works in 2005 to 2 in 2022.
1
1
2
1
2
1
1
2
20052008201120122013201420202022
What are the most-cited papers on Alberto J. Montero?
ScholarIQmost cited works
Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin–cyclophosphamide chemotherapy
C. Marcela Díaz‐Montero, Mohamed L. Salem, Michael I. Nishimura, Elizabeth Garrett‐Mayer, David J. Cole, Alberto J. Montero
S203303425. 20081,208 Citations
Elacestrant (oral selective estrogen receptor degrader) Versus Standard Endocrine Therapy for Estrogen Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer: Results From the Randomized Phase III EMERALD Trial
François‐Clément Bidard, Virginia Kaklamani, Patrick Neven, Guillermo Streich, Alberto J. Montero, Frédéric Forget, Marie‐Ange Mouret‐Reynier, Joohyuk Sohn, Donatienne Taylor, Kathleen Harnden, Hung T. Khong, Judit Kocsis, Florence Dalenc, Patrick M. Dillon, Sunil Babu, Simon Waters, Ines Deleu, José Á. García-Sáenz, Emilio Bria, Marina Elena Cazzaniga, Janice Lu, Philippe Aftimos, Javier Cortés, Shubin Liu, Giulia Tonini, Dirk Laurent, Nassir Habboubi, Maureen G. Conlan, Aditya Bardia
Journal of Clinical Oncology. 2022719 CitationsOPEN ACCESS
A human promyelocytic-like population is responsible for the immune suppression mediated by myeloid-derived suppressor cells
Samantha Solito, Erika Falisi, C. Marcela Díaz‐Montero, Andrea Doni, Laura Pinton, Antonio Rosato, Samuela Francescato, Giuseppe Basso, Paola Zanovello, Georgiana Onicescu, Erik Mayer, Alberto J. Montero, Vincenzo Bronte, Susanna Mandruzzato
Blood. 2011335 CitationsOPEN ACCESS
Docetaxel for treatment of solid tumours: a systematic review of clinical data
Alberto J. Montero, Frank V. Fossella, Gabriel N. Hortobágyi, Vicente Valero
The Lancet Oncology. 2005309 Citations
Novel HER2–targeted therapies for HER2–positive metastatic breast cancer
Siddharth Kunte, Jame Abraham, Alberto J. Montero
Cancer. 2020217 CitationsOPEN ACCESS
Related on ScholarIQ
University Hospitals of Cleveland
Institution
Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin–cyclophosphamide chemotherapy
Paper
Elacestrant (oral selective estrogen receptor degrader) Versus Standard Endocrine Therapy for Estrogen Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer: Results From the Randomized Phase III EMERALD Trial
Paper
A human promyelocytic-like population is responsible for the immune suppression mediated by myeloid-derived suppressor cells
Paper
Docetaxel for treatment of solid tumours: a systematic review of clinical data
Paper
Novel HER2–targeted therapies for HER2–positive metastatic breast cancer
Paper